Assays

Venor® Mycoplasma qPCR is a validated real-time RT-qPCR kit for the rapid, sensitive, and reliable detection of mycoplasma contamination in cell cultures, biopharmaceutical products, and advanced therapy medicinal products (ATMPs). The assay detects both RNA and DNA targets, providing enhanced sensitivity ...

Biopharmaceutical Characterization & Testing: By leveraging expert insight into a biologic’s structure, physicochemical properties, potency, and impurity profile, we help you achieve critical development milestones with confidence.

A range of expertise is available, includin...

1.MateriaBoth the inner and outer chambers are constructed from 304 stainless steel, featuring enhanced corrosion resistance and wide environmental adaptability.
2.System
Equipped with a large-screen color touchscreen controller, which includes multi-level user permissions and audit trail functions. ...

The MiQuant® AAV ITR 2/6 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

This kit provides a primer/probe mix that enables specific detection of AAV genotypes 2 and 6 by amplifying the respectiv...

The MiQuant® AAV ITR 5 – dPCR kit is an easy to use, rapid and sensitive solution for adeno-associated virus (AAV) vector titer testing based on digital PCR (dPCR).

This kit provides a primer/probe mix that enables specific detection of AAV genotype 5 by amplifying the respective inverte...

The MiQuant® Residual DNA HEK-293 – dPCR is suitable for the quantitative detection of residual DNA from host cells in chemical and biological matrices. This kit contains a specific primer/probe mix and provides an open platform solution for use on various dPCR instruments (QIAcuity®, ddPCR™, Quant...

Brightlabs has in-house validated methods for the analysis of elemental impurities in accordance to ICH-Q3D. Brightlabs has a unique approach for ICHQ3D, which guarantees quick turnaround times at reduced cost

Since 2018 Brightlabs possesses an opium exemption from the BMC (Bureau for Medicinal Cannabis), for the analysis of cannabis and related products. The combination of this opium exemption, combined with our GMP accreditation, makes Brightlabs an important partner for the analysis of cannabis and related ma...

For 500x12 µl reactions (20x): QIAGEN Cell and Gene Therapy assay for GFP to be used with the QIAcuity dPCR system.

Features
• A broad offering of ten different wet-lab validated dPCR CGT assays • Assays with different fluorophore choices allow multiplexing to sustain vector integrity • An e...

The dPCR Microbial DNA Detection Assays are designed to test for the presence of bacterial, fungal, parasitic, viral, antibiotic resistance or virulence factor genes using digital PCR. The assays can be run on the QIAcuity® in about two hours with minimal hands-on time. The assays target over 680 bacterial...

Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays. Key assays include SPR, Kinase, ADP-Glo, TR-FRET, FP, Cali...